Improving the management of people with bronchiectasis in Saudi: A new beginning.

Authors:
Anne B Chang
Anne B Chang
Royal Children's Hospital
Australia

Ann Thorac Med 2017 Jul-Sep;12(3):133-134

Department of Respiratory and Sleep Medicine, Lady Cilento Children's Hospital, Brisbane, Australia.

PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
Source Status
http://dx.doi.org/10.4103/atm.ATM_183_17DOI ListingPossible
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541961PMCFound
August 2017
4 Reads

Similar Publications

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Ann Thorac Med 2017 Jul-Sep;12(3):135-161

International Reviewer, Department of Pathophysiology and Transplantation, University of MilanInternal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Via Francesco Sforza 35, 20122, Milan, Italy.

This is the first guideline developed by the Saudi Thoracic Society for the diagnosis and management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists, infectious disease specialists, thoracic surgeons, respiratory therapists, and others from adult and pediatric departments provided the best practice evidence recommendations based on the available international and local literature. The main objective of this guideline is to utilize the current published evidence to develop recommendations about management of bronchiectasis suitable to our local health-care system and available resources. Read More

View Article
August 2017

Prevalence and risk factors of asymptomatic bronchiectasis in patients with rheumatoid arthritis at a tertiary care center in Saudi Arabia.

Ann Thorac Med 2015 Jul-Sep;10(3):176-80

Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

Introduction And Objectives: Bronchiectasis is a pulmonary manifestation that often occurs in individuals with rheumatoid arthritis (RA). Nevertheless, the prevalence of bronchiectasis in RA patients and predictors of its development/progression remain ill-defined. Our objective was to investigate the prevalence of bronchiectasis in a group of RA patients and examine possible clinical or biochemical risk factors that might contribute to its development. Read More

View Article
August 2015

Bronchiectasis: new approaches to diagnosis and management.

Authors:
Charles Feldman

Clin Chest Med 2011 Sep;32(3):535-46

Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Parktown, Johannesburg, South Africa.

Non-cystic fibrosis (CF) bronchiectasis is a common, potentially serious, condition. Further investigations should be performed in an attempt to identify the underlying cause because it may lead to a change in therapy and have significant prognostic implications. MRI is being investigated as a radiation free alternative to high-resolution CT scan of the chest. Read More

View Article
September 2011

Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis.

Cochrane Database Syst Rev 2016 Jan 27(1):CD007525. Epub 2016 Jan 27.

Child Health Division, Menzies School of Health Research, Charles Darwin University, Royal Darwin Hospital Campus, Darwin, Northern Territory, Australia, 0811.

Background: Chronic neutrophilic inflammation, in both the presence and absence of infection, is a feature of bronchiectasis in adults and children. The anti-inflammatory properties of non-steroid anti-inflammatory drugs (NSAIDs) may be beneficial in reducing airway inflammation, thus potentially improving lung function and quality of life in patients with bronchiectasis.

Objectives: To evaluate the efficacy of inhaled NSAIDs in the management of non-cystic fibrosis bronchiectasis in children and adults:• during stable bronchiectasis; and• for reduction of:∘ severity and frequency of acute respiratory exacerbations; and∘ long-term pulmonary decline. Read More

View Article
January 2016